HomeALPMF • OTCMKTS
add
Astellas Pharma Inc
Previous close
$10.60
Day range
$11.26 - $11.26
Year range
$9.13 - $12.74
Market cap
2.76T JPY
Avg Volume
791.00
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
In the news
Financials
Income Statement
Revenue
Net income
| (JPY) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 462.50B | 17.94% |
Operating expense | 341.78B | 7.88% |
Net income | 35.91B | 1,239.35% |
Net profit margin | 7.76 | 1,041.18% |
Earnings per share | — | — |
EBITDA | 88.05B | 120.73% |
Effective tax rate | 6.85% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 292.99B | -12.28% |
Total assets | 3.46T | -2.28% |
Total liabilities | 1.93T | 1.51% |
Total equity | 1.53T | — |
Shares outstanding | 1.79B | — |
Price to book | 0.01 | — |
Return on assets | 2.64% | — |
Return on capital | 3.70% | — |
Cash Flow
Net change in cash
| (JPY) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 35.91B | 1,239.35% |
Cash from operations | 64.81B | 75.72% |
Cash from investing | -16.38B | 97.88% |
Cash from financing | -54.34B | -110.76% |
Net change in cash | -9.94B | 95.63% |
Free cash flow | 43.59B | -17.69% |
About
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Founded
Apr 1, 2005
Headquarters
Website
Employees
14,754
